Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion type Assertion NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_head.
- NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion description "[The majority of papillomas in control mice regressed after termination of 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment, whereas p53m papillomas progressed to carcinomas and metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_provenance.
- NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion evidence source_evidence_literature NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_provenance.
- NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion SIO_000772 9671312 NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_provenance.
- NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion wasDerivedFrom befree-20140225 NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_provenance.
- NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_assertion wasGeneratedBy ECO_0000203 NP415103.RAv1RodceHSiR0_Ru9qh0mU3AnUjcrCFmZ6YPWanIC5kA130_provenance.